Canadian SIRIUS: Canadian study of sirolimus-eluting stents vs uncoated stents

      -Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Coronary Artery Lesions by Dr. Erick Schampaert

CEREA-DES: Cortisone Plus BMS or DES versus BMS Alone to Eliminate Restenosis

      -A Prospective Randomzied Trial of Corticosteroids in Patients Undergoing Stent Implantation by Dr. Flavio Ribichini (TCT 2009)

DELIVER: paclitaxel-coated RX ACHIEVE™ Drug-Eluting Coronary Stent System (CSS) vs. the metallic MULTI-LINK RX PENTA™ CSS in patients with de novo coronary lesions

      -Paclitaxel-Eluting Stent in the Treatment of Patients with De Novo Coronary Artery Lesions

EuroSTAR II: The European Randomized CoStar

      -Cobalt-Chromium Paclitaxel-eluting Stent vs. identical BMS by Dr. Sigmund Silber

HORIZONS-AMI: Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction

      -Two-Year Follow-up from a Prospective, Randomized Trial of Heparin Plus Glycoprotein IIb/IIIa Inhibitors vs. Bivalirudin and Paclitaxel-Eluting vs. Bare-Metal Stents in STEMI by Dr. Gregg Stone (TCT 2009)

Mass-DAC Registry: Massachusetts Data Analysis Center

      -Drug-Eluting and Bare Metal Stenting for Diabetes Mellitus by Dr. Laura Mauri

OCTAMI: A Prospective, Randomized, Controlled Study Performed with Optical Coherence Tomography

      -Six-Month Strut Coverage and Vessel Wall Response of the Zotarolimus Eluting Stent Compared to Driver Bare Metal Stent Implanted in AMI by Dr. Giulio Guagliumi, et al. (TCT 2009)

PASEO: Paclitaxel- or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty

      -Long-term Outcome of Drug-eluting Stents Compared with Bare Metal Stents in ST-segment Elevation Myocardial Infarction by Dr. Emilio Di Lorenzo

PASSION: Paclitaxel Eluting Stent Versus Conventional Stent in ST-segment Elevation Myocardial Infarction

      -Taxus vs Bare Metal stent in STEMI by Dr. Maurits T. Dirksen

RAVEL Long-term (1 term): A RAndomised (double blind) study with the Sirolimus coated BX™ VElocity balloon expandable stent (CYPHER™) in the treatment of patients with De Novo native coronary artery Lesions

      -Sirolimus releasing stents (Cypher) vs standard uncoated stents in patients undergoing PCI by Dr. M.C. Morice

SCAAR Swedish Coronary Angiography and Angioplasty Registry

      -Drug Eluting Stents Vs. Bare Metal Stents in Sweden by Dr. Stefan James

SESAMI: Randomized trial of Sirolimus Stent vs Bare Stent in Acute Myocardial Infarction

      -Sirolimus Stent Vs Bare Metal Stent in Patients with Acute Myocardial Infarction by Dr. Mauricio Menichelli

STRATEGY: Sirolimus Eluting Stents Vs. Bare Metal Stents Implantation Assisted by Systematic GP IIb/IIIa Infusion in Patients with MI

      -Sirolimus-eluting versus bare metal stent implantation with systematic GP IIb/IIIa infusion in patients with MI: Three year follow-up by Dr. Marco Valgimigli

SVG Intervention: Late "Catch-Up" in Target Vessel Revascularization with DES vs BMS

      -Two Year Results from the STENT Group by Dr. Bruce R Brodie (TCT 2009)

TAXUS 2: Sirolimus Eluting Stents Vs. Bare Metal Stents Implantation Assisted by Systematic GP IIb/IIIa Infusion in Patients with MI

      -Moderate release paclitaxel-eluting stent vs bare stent in de novo lesions

      -Slow release paclitaxel-eluting stent vs bare stent in de novo lesions

TAXUS 2 and 4

      -Paclitaxel-eluting stent versus BMS: Two year Follow-up

TAXUS IV Sirolimus Eluting Stents Vs. Bare Metal Stents Implantation Assisted by Systematic GP IIb/IIIa Infusion in Patients with MI

      -2 Year follow up data

      -Slow-rate release polymer-based paclitaxel-eluting stent compared with bare stent in patients with single de novo coronary lesions

      -2 Year follow up data

TAXUS V

      -Outcomes of the Polymer-based, Paclitaxel-eluting TAXUS Stent in Complex Lesions by Dr. Gregg Stone

TAXUS V ISR

      -Trial of Taxus stent vs brachytherapy for in stent by Dr. Gregg Stone

Taxus ATLAS

      -Evaluation of TAXUS Liberté vs. TAXUS Express Trial by Dr. Mark Turco

      -SMALL VESSEL and LONG LESION: First Report of Nine-Month Clinical and Angiographic Results by Dr. Mark Turco

      -WORKHORSE and DIRECT STENT First Report of Nine and Twelve Month Clinical and Angiographic Results by Dr. Mark Turco and John A. Ormiston

      -Small vessel and long lesion: First Report of Nine-Month Clinical and Angiographic Results by Dr. Mark Turco

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs